- Clinical significance of determining the hypermethylation of the RUNX3 gene promoter and its cohypermethylation with the BRCA1 gene for patients with breast cancer
Zoia Rossokha et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef - DIAGNOSTIC VALUE OF EXOSOMAL MIRNAS FOR COLORECTAL CANCER
R. B. Samsonov et al, 2018, Koloproktologia CrossRef - Relation of the methylation state of RUNX3 and p16 gene promoters with hepatocellular carcinoma in Egyptian patients
Fatma El-shaarawy et al, 2022, Egyptian Journal of Medical Human Genetics CrossRef - Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas
Xie Zhang, 2015, World Journal of Gastroenterology CrossRef - Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsy
I. F. Kustova et al, 2019, Advances in molecular oncology CrossRef - New trends in molecular and cellular biomarker discovery for colorectal cancer
Parisa Aghagolzadeh et al, 2016, World Journal of Gastroenterology CrossRef - Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
Michail Galanopoulos et al, 2017, World Journal of Gastrointestinal Oncology CrossRef - Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
Wataru Okajima et al, 2017, World Journal of Gastroenterology CrossRef - Methylation status of RASSF1A associates with prognosis in metastatic gastric cancer
Evangelos Karamitrousis et al, 2019, Gastroenterology & Hepatology: Open Access CrossRef - Colorectal Cancer Blood-Based Biomarkers
Nina Hauptman et al, 2017, Gastroenterology Research and Practice CrossRef - Pathogenetic mechanisms in gastric cancer
Jing Shi, 2014, World Journal of Gastroenterology CrossRef - Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
Negesse Mekonnen et al, 2022, Frontiers in Oncology CrossRef - Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients
Yu-Cai Wang et al, 2008, World Journal of Gastroenterology CrossRef